Keywords: msd, takes, control, amrad, pharma, corp, agreed
MSD takes control of Amrad Pharma
Article | 14 September 2000
Amrad Corp has agreed to sell its 55% ownership of Amrad Pharmaceuticalsto Merck Sharp & Dohme (Australia) for A$20.8 million ($11.7 million) over ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
